Gavin Maggs, chief executive of Children with Cancer UK, added: “The projects we’re funding are not just advancing scientific knowledge, they have the potential to fundamentally change how these cancers are diagnosed and treated, offering children safer and more effective options than ever before.
Trending
- Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
- Steel Particulate Matter Prompts Cyclophosphamide for Injection Recall
- Amy Dowden says Strictly Come Dancing partner Carlos Gu convinced her not to quit dancing
- Navigating Insurance Hurdles for Oral AML Therapy Access
- Ris-Rez Hits PFS End Point in Phase 3 Osteosarcoma Trial
- Cretostimogene Grenadenorepvec Shows Complete Responses in NMIBC
- The Power of Waiting When You Don’t Know What to Do
- Low-fat dietary pattern and dietary advanced glycation end-products intake: a secondary analysis of the Women’s Health Initiative randomized trial
Tuesday, July 28
